(Q40889713)

English

Levels of plasminogen activator inhibitor type 1 and urokinase plasminogen activator receptor in non-small cell lung cancer as measured by quantitative ELISA and semiquantitative immunohistochemistry

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 September 2017

Levels of plasminogen activator inhibitor type 1 and urokinase plasminogen activator receptor in non-small cell lung cancer as measured by quantitative ELISA and semiquantitative immunohistochemistry (English)

1 reference

Europe PubMed Central

24 September 2017

immunohistochemistry

1 reference

based on heuristic

inferred from title

author name string

Pappot H

1

1 reference

Europe PubMed Central

24 September 2017

Skov BG

2

1 reference

Europe PubMed Central

24 September 2017

Pyke C

3

1 reference

Europe PubMed Central

24 September 2017

Grøndahl-Hansen J

4

1 reference

Europe PubMed Central

24 September 2017

publication date

1 July 1997

1 reference

Europe PubMed Central

24 September 2017

1 reference

Europe PubMed Central

24 September 2017

17

1 reference

Europe PubMed Central

24 September 2017

2-3

1 reference

Europe PubMed Central

24 September 2017

197-209

1 reference

Europe PubMed Central

24 September 2017

Plasminogen activator inhibitors: hormonally regulated serpins

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900032-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved medium for extraction of plasminogen activator from tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900032-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasminogen Activation by Receptor-Bound Urokinase

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900032-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The urokinase receptor: involvement in cell surface proteolysis and cancer invasion

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900032-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The content of urokinase-type plasminogen activator and tumor recurrence in superficial bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900032-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical relevance of the urokinase-type and tissue-type plasminogen activators and of their type 1 inhibitor in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900032-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasminogen activator inhibitor-type 1 in Lewis lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900032-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Lung cancer classification: the relationship of disease extent and cell type to survival in a clinical trials population

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900032-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Urokinase-type plasminogen activator and outcome in Dukes' B colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900032-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasminogen activators and their inhibitors in non-small cell lung cancer. Low content of type 2 plasminogen activator inhibitor associated with tumor dissemination

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900032-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunohistochemical localization of coagulation, fibrinolytic and antifibrinolytic markers in adenocarcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900032-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumour-associated proteolytic factors uPA and PAI-1 and survival in totally resected gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900032-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Coexisting macrophage-associated fibrin formation and tumor cell urokinase in squamous cell and adenocarcinoma of the lung tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900032-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The plasminogen activation system and its role in lung cancer. A review

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900032-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunohistochemical detection of the receptor for urokinase plasminogen activator in human colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900032-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Type-1 plasminogen activator inhibitor in human breast carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900032-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Urokinase receptor in breast cancer tissue extracts. Enzyme-linked immunosorbent assay with a combination of mono- and polyclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900032-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Cell-associated plasminogen activation: regulation and physiological functions

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900032-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunolocalization of urokinase-type plasminogen activator in adenomas and carcinomas of the colorectum.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900032-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A better cell line for making hybridomas secreting specific antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900032-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0169-5002(97)00032-9

1 reference

Europe PubMed Central

24 September 2017

1 reference

Europe PubMed Central

24 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40889713&oldid=1909610141"